<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title> Nirmatrelvir 在最新试验中未能缩短 COVID-19 症状</title><description>《新英格兰医学杂志》上的一项研究评估了尼马瑞韦和利托那韦联合治疗 COVID-19 的效果，发现它并不能显着缩短接种疫苗或未接种疫苗的成人门诊患者的症状持续时间。</description><link/> https://www.news-medical.net/news/20240408/Nirmatrelvir-fails-to-shorten-COVID-19-symptoms-in-latest-Trial.aspx<comments> https://www.news-medical.net/news/20240408/Nirmatrelvir-fails-to-shorten-COVID-19-symptoms-in-latest-Trial.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=9540e59e-7471-4acf-b48c-82e98d5c8c6e</guid><pubDate> Mon, 08 Apr 2024 22:03:00 -0400</pubDate> <media:content expression="full" height="1333" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_776655_1712627001072746.jpg" width="2000"><media:description><![CDATA[Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial]]></media:description></media:content></item><item><title>丹麦的百日咳疫情揭示了孕产妇疫苗接种的力量</title><description>《Eurosurveillance》上发表的一项研究详细介绍了 2023 年丹麦百日咳疫情，强调了特定年龄的发病率、孕产妇疫苗接种在减少婴儿住院治疗方面的作用，以及疫苗接种策略对控制疫情的影响。</description><link/> https://www.news-medical.net/news/20240408/Denmarks-pertussis-epidemic-reveals-the-power-of-maternal-vaccination.aspx<comments> https://www.news-medical.net/news/20240408/Denmarks-pertussis-epidemic-reveals-the-power-of-maternal-vaccination.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8d9fcc78-fa39-49b5-ba43-70de717c3b4d</guid><pubDate> Mon, 08 Apr 2024 21:56:00 -0400</pubDate> <media:content expression="full" height="1125" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_776648_17126187119717720.jpg" width="2000"><media:description><![CDATA[Denmark's pertussis epidemic reveals the power of maternal vaccination]]></media:description></media:content></item><item><title> SMART 试验显示两种常见 TAVR 设备在小主动脉环患者中的结果相当</title><description>主动脉环较小（心脏解剖结构的一部分，左心室与主动脉交汇处）的患者接受超环自扩张瓣膜经导管主动脉瓣置换术 (TAVR) 后，一年后可看到类似的临床结果和优越的瓣膜性能根据美国心脏病学会年度科学会议上发表的研究，与接受球囊扩张瓣膜 TAVR 的患者进行比较。</description><link/> https://www.news-medical.net/news/20240408/SMART-trial-shows-comparable-outcomes-of-two-common-TAVR-devices-in-small-aortic-annulus-病人.aspx<comments> https://www.news-medical.net/news/20240408/SMART-trial-shows-comparable-outcomes-of-two-common-TAVR-devices-in-small-aortic-annulus-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=a250f9f9-279c-4430-9ce5-e7ecc74fc87f</guid><pubDate> Mon, 08 Apr 2024 16:03:11 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/heart-620x480.jpg" width="620"><media:description><![CDATA[SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients]]></media:description></media:content></item><item><title>乙二胺四乙酸二钠螯合剂对糖尿病心脏病患者无效</title><description>心脏病发作的糖尿病患者不会从基于乙二胺四乙酸二钠的螯合疗法中获得任何临床益处，这种疗法会将铅和其他有毒金属排出体外，这些金属与心脏病和中风的风险增加有关。美国心脏病学会年度科学会议。</description><link/> https://www.news-medical.net/news/20240408/Edetate-disodium-based-chelation-in effective-for-heart-attack-病人-with-diabetes.aspx<comments> https://www.news-medical.net/news/20240408/Edetate-disodium-based-chelation-in effective-for-heart-attack-病人-with-diabetes.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=99e8ca6a-f7a0-4426-a039-1194925c5bab</guid><pubDate> Mon, 08 Apr 2024 15:59:43 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Heart_Attack-620x480.jpg" width="620"><media:description><![CDATA[Edetate disodium-based chelation ineffective for heart attack patients with diabetes]]></media:description></media:content></item><item><title>研究表明替格瑞洛单药治疗可降低经皮冠状动脉介入治疗后的出血风险</title><description>患有心脏病或有心脏病发作风险的患者，在接受经皮冠状动脉介入治疗 (PCI) 1 个月后停止服用阿司匹林和 P2Y12 抑制剂替格瑞洛，发现有临床意义的出血风险显着降低，且出血风险并未增加。在美国心脏病学会年度科学会议上发表的一项研究显示，与继续服用阿司匹林和替格瑞洛一整年的患者相比，12 个月时出现了与凝血相关的不良事件。</description><link/> https://www.news-medical.net/news/20240408/Study-shows-reduced-bleeding-risk-with-ticagrelor-monotherapy-after-per表皮-冠状动脉-intervention.aspx<comments> https://www.news-medical.net/news/20240408/Study-shows-reduced-bleeding-risk-with-ticagrelor-monotherapy-after-per表皮-冠状动脉-intervention.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8120f1d0-1e3e-4d8f-a382-892a0595f966</guid><pubDate> Mon, 08 Apr 2024 15:56:50 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Aspirin-620x480.jpg" width="620"><media:description><![CDATA[Study shows reduced bleeding risk with ticagrelor monotherapy after percutaneous coronary intervention]]></media:description></media:content></item><item><title> Lerodalcibep 可将高危患者的 LDL 胆固醇降低 50% 以上</title><description>在心脏病或中风高风险或极高风险的患者中，与标准降胆固醇药物相比，在标准降胆固醇药物中添加研究药物 lerodalcibep 一年后，LDL（“坏”胆固醇）水平平均降低一半以上。安慰剂。</description><link/> https://www.news-medical.net/news/20240408/Lerodalcibep-reduces-LDL-cholesterol-by-over-5025-in-high-risk-患者.aspx<comments> https://www.news-medical.net/news/20240408/Lerodalcibep-reduces-LDL-cholesterol-by-over-5025-in-high-risk-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=ece9308e-1630-4ed0-9cce-9795d2e83dc2</guid><pubDate> Mon, 08 Apr 2024 13:40:39 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Cholesterol-620x480.jpg" width="620"><media:description><![CDATA[Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients]]></media:description></media:content></item><item><title> Impella CP 泵在心源性休克中显示出生存优势</title><description>根据美国心脏病学会年度科学会议上发表的一项研究，在心脏病发作后数小时内植入 Impella CP 微型轴流泵可显着提高心源性休克患者六个月后的存活率。</description><link/> https://www.news-medical.net/news/20240408/Impella-CP-pump-shows-survival-benefit-in-cardiogenic-shock.aspx<comments> https://www.news-medical.net/news/20240408/Impella-CP-pump-shows-survival-benefit-in-cardiogenic-shock.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=c61db512-0daf-4aeb-b6ee-91c38cd7ff2f</guid><pubDate> Mon, 08 Apr 2024 13:36:37 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Anatomy_of_Human_Heart.-Liya_Graphics_5ac9d64765b747899bc4a9ef77468432-620x480.jpg" width="620"><media:description><![CDATA[Impella CP pump shows survival benefit in cardiogenic shock]]></media:description></media:content></item><item><title>新型胆固醇清除策略显示出心脏病发作后的潜在益处</title><description>根据美国心脏病学会年度科学会议上发表的研究，从患者动脉中清除胆固醇的新策略的首次试验并没有降低心脏病发作后三个月内死亡、心脏病或中风的风险。然而，研究结果表明，随着更长时间的随访，该策略可能会有所帮助。</description><link/> https://www.news-medical.net/news/20240408/Novel-cholesterol-removal-strategy-shows-pottial-benefits-post-heart-attack.aspx<comments> https://www.news-medical.net/news/20240408/Novel-cholesterol-removal-strategy-shows-pottial-benefits-post-heart-attack.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=e028ed61-c99f-4214-99ae-b74a3c40f3fb</guid><pubDate> Mon, 08 Apr 2024 13:28:23 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/6/Blood_cells_in_an_artery._3d_illustration_-_Illustration_-_crystal_light_M1_8c651e0f390a4b0f98d381ffd0a34055-620x480.jpg" width="620"><media:description><![CDATA[Novel cholesterol removal strategy shows potential benefits post-heart attack]]></media:description></media:content></item><item><title>研究：恩格列净对心脏病发作患者的结果好坏参半</title><description>根据美国心脏病学会年度科学杂志上发表的一项研究，心脏病发作后使用钠葡萄糖协同转运蛋白 2 (SGLT-2) 抑制剂恩格列净并没有显示出对减少总体心力衰竭住院或任何原因死亡的显着益处。会议。</description><link/> https://www.news-medical.net/news/20240408/Study-Empagliflozin-shows-mixed-results-in-heart-attack-病人.aspx<comments> https://www.news-medical.net/news/20240408/Study-Empagliflozin-shows-mixed-results-in-heart-attack-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=ada794ff-493b-43ec-a16a-e9567751a2a4</guid><pubDate> Mon, 08 Apr 2024 13:21:57 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/5/3d_rendered_illustration_-_heart_attack-Sebastian_Kaulitzki_d8743c68eb3c4250817a2a23a847caeb-620x480.jpg" width="620"><media:description><![CDATA[Study: Empagliflozin shows mixed results in heart attack patients]]></media:description></media:content></item><item><title>研究为高龄候选人肺移植提供了见解</title><description>国际心肺移植协会（ISHLT）的数据显示，到2017年，66岁及以上的受移植者比例已上升至19%。</description><link/> https://www.news-medical.net/news/20240408/Study-provides-insights-on-lung-transplantation-in-advanced-age-candidates.aspx<comments> https://www.news-medical.net/news/20240408/Study-provides-insights-on-lung-transplantation-in-advanced-age-candidates.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8d883850-f883-4ee7-abef-661038c06c98</guid><pubDate> Mon, 08 Apr 2024 13:15:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/4/Anatomically_correct_3d_model_of_human_heart-u3d_2cbbdab779c84457877be90c0f055b76-620x480.jpg" width="620"><media:description><![CDATA[Study provides insights on lung transplantation in advanced age candidates]]></media:description></media:content></item></channel></rss>